James W. Shaw

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text

Medicine, Oncology, Metastasis +5

US Valuation of the EQ-5D Health States

James W. Shaw, Jeffrey Johnson, Stephen Joel Coons · Medical Care · 2005 · 1.3K citations

Pharmacy, Population Health Sciences, Health Assessment +16

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein et al. · The Lancet Oncology · 2017 · 430 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index

Nan Luo, Jeffrey Johnson, James W. Shaw et al. · Medical Care · 2005 · 392 citations

Pharmacy, Population Health Sciences, Health Assessment +16

United States Valuation of EQ-5D-5L Health States Using an International Protocol

A. Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health · 2019 · 391 citations · Full text

Pharmacy, Educational Measurement, Health Assessment +16